Skip to main content
. Author manuscript; available in PMC: 2023 Mar 9.
Published in final edited form as: Int J Drug Policy. 2021 Dec 13;101:103558. doi: 10.1016/j.drugpo.2021.103558

Table 2.

Characteristics of those released from prison who were prescribed methadone during incarceration (n = 645).

Variables Frequency %

Age at release (years), mean (±SD) 37.1 (±7.8)
Male 618 95.8
Released to Greater Bishkek area 622 96.4
HIV status, positive (n = 569) 160 28.1
Duration of current incarceration (months), mean (±SD) 31.6 (±23.8)
Percentage of time on methadone in prison, mean (±SD) 47.1 (±40.0)
On methadone in community upon prison entry
 No 620 96.1
 Yes 25 3.9
Methadone start dose in prison
 Low (≤40 mg) 542 84.0
 Medium (>40–85 mg) 93 14.4
 High (>85 mg) 10 1.6
Maximum methadone dose in prison
 Low (≤40 mg) 142 22.0
 Medium (>40–85 mg) 323 50.1
 High (>85 mg) 180 27.9
Methadone dose at the time of release
 Not on methadone 358 55.5
 Low (1–40 mg) 91 14.1
 Medium (>40–85 mg) 135 20.9
 High (>85 mg) 61 9.5
Rapid taper off methadone upon prison entry 112 17.4
Linked to methadone in community after release 128 19.8
Time to linkage to methadone in community (n = 128)
 Within 7 days 79 61.9
 Within 30 days 15 11.7
 Within 90 days 7 5.4
 >90 days 27 21.1
Reincarcerated 47 7.3
Died post release 48 7.5
Methadone start dose in community (n = 128)
 Low (≤40 mg) 54 42.5
 Medium (>40–85 mg) 52 40.9
 High (>85 mg) 21 16.5
Maximum methadone dose in community (n = 128)
 Low (≤40 mg) 15 11.8
 Medium (>40–85 mg) 67 52.8
 High (>85 mg) 45 35.4
Last post-release methadone dose in community (n = 128)
 Low (≤40 mg) 59 47.2
 Medium (>40–85 mg) 43 34.4
 High (>85 mg) 23 18.4
Duration on methadone in community (months), mean (±SD) 9.2 (±10.4)